Ventricular Function, Left
"Ventricular Function, Left" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The hemodynamic and electrophysiological action of the left HEART VENTRICLE. Its measurement is an important aspect of the clinical evaluation of patients with heart disease to determine the effects of the disease on cardiac performance.
Concept/Terms
Ventricular Function, Left- Ventricular Function, Left
- Left Ventricular Function
- Function, Left Ventricular
- Functions, Left Ventricular
- Left Ventricular Functions
- Ventricular Functions, Left
Below are MeSH descriptors whose meaning is more general than "Ventricular Function, Left".
Below are MeSH descriptors whose meaning is more specific than "Ventricular Function, Left".
This graph shows the total number of publications written about "Ventricular Function, Left" by people in Harvard Catalyst Profiles by year, and whether "Ventricular Function, Left" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1993 | 27 | 17 | 44 |
1994 | 16 | 21 | 37 |
1995 | 13 | 13 | 26 |
1996 | 4 | 15 | 19 |
1997 | 12 | 8 | 20 |
1998 | 7 | 23 | 30 |
1999 | 9 | 12 | 21 |
2000 | 7 | 16 | 23 |
2001 | 6 | 11 | 17 |
2002 | 8 | 16 | 24 |
2003 | 14 | 22 | 36 |
2004 | 8 | 16 | 24 |
2005 | 11 | 15 | 26 |
2006 | 11 | 15 | 26 |
2007 | 16 | 11 | 27 |
2008 | 22 | 19 | 41 |
2009 | 25 | 29 | 54 |
2010 | 22 | 28 | 50 |
2011 | 25 | 27 | 52 |
2012 | 42 | 31 | 73 |
2013 | 36 | 30 | 66 |
2014 | 50 | 23 | 73 |
2015 | 57 | 27 | 84 |
2016 | 52 | 29 | 81 |
2017 | 67 | 36 | 103 |
2018 | 61 | 40 | 101 |
2019 | 73 | 46 | 119 |
2020 | 70 | 83 | 153 |
2021 | 29 | 98 | 127 |
2022 | 16 | 137 | 153 |
2023 | 1 | 8 | 9 |
Below are the most recent publications written about "Ventricular Function, Left" by people in Profiles.
-
Dapagliflozin and All-Cause Hospitalizations in Patients With Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol. 2023 Mar 14; 81(10):1004-1006.
-
Impact of Diabetes and Hypertension on Left Ventricular Structure and Function: The Jackson Heart Study. J Am Heart Assoc. 2023 Mar 21; 12(6):e026463.
-
Firibastat Versus Ramipril After Acute Mechanical Reperfusion of Anterior Myocardial Infarction: A Phase 2 Study. Am J Cardiovasc Drugs. 2023 Mar; 23(2):207-217.
-
Epidemiology and Outcomes of Aortic Stenosis in Acute Decompensated Heart Failure: The ARIC Study. Circ Heart Fail. 2023 Mar; 16(3):e009653.
-
Cardiac and obstetric outcomes of pregnancies for women after cardiotoxic therapy in childhood: a single center observational study. BMC Cancer. 2023 Feb 02; 23(1):115.
-
Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials. Int J Cardiol. 2023 Apr 15; 377:86-88.
-
Reply: Blood Pressure and Lack of Association With Treatment Benefits of Dapagliflozin in HFpEF and HFmrEF. JACC Heart Fail. 2023 02; 11(2):261-262.
-
Dapagliflozin in Heart Failure with Preserved Ejection Fraction. Reply. N Engl J Med. 2023 01 19; 388(3):288.
-
Population-Level Implications of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Preserved Ejection Fraction in the US. JAMA Cardiol. 2023 01 01; 8(1):66-73.
-
Cardiac strain is lower among women with HIV in relation to monocyte activation. PLoS One. 2022; 17(12):e0279913.